16-88427506-C-G
Position:
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 2P and 13B. PM2BP4_StrongBP6_Very_StrongBP7
The NM_001367624.2(ZNF469):āc.36C>Gā(p.Pro12Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000098 in 1,531,360 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.000013 ( 0 hom., cov: 34)
Exomes š: 0.0000094 ( 1 hom. )
Consequence
ZNF469
NM_001367624.2 synonymous
NM_001367624.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -3.05
Genes affected
ZNF469 (HGNC:23216): (zinc finger protein 469) This gene encodes a zinc-finger protein. Low-percent homology to certain collagens suggests that it may function as a transcription factor or extra-nuclear regulator factor for the synthesis or organization of collagen fibers. Mutations in this gene cause brittle cornea syndrome. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -11 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 16-88427506-C-G is Benign according to our data. Variant chr16-88427506-C-G is described in ClinVar as [Likely_benign]. Clinvar id is 2892815.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.05 with no splicing effect.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF469 | NM_001367624.2 | c.36C>G | p.Pro12Pro | synonymous_variant | 3/3 | ENST00000565624.3 | NP_001354553.1 | |
ZNF469 | XM_047434810.1 | c.36C>G | p.Pro12Pro | synonymous_variant | 4/4 | XP_047290766.1 | ||
LOC112268182 | XR_007065178.1 | n.251-1240G>C | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF469 | ENST00000565624.3 | c.36C>G | p.Pro12Pro | synonymous_variant | 3/3 | 6 | NM_001367624.2 | ENSP00000456500.2 | ||
ZNF469 | ENST00000437464.1 | c.36C>G | p.Pro12Pro | synonymous_variant | 1/2 | 5 | ENSP00000402343.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152156Hom.: 0 Cov.: 34
GnomAD3 genomes
AF:
AC:
2
AN:
152156
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000154 AC: 2AN: 130234Hom.: 0 AF XY: 0.0000141 AC XY: 1AN XY: 71012
GnomAD3 exomes
AF:
AC:
2
AN:
130234
Hom.:
AF XY:
AC XY:
1
AN XY:
71012
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000943 AC: 13AN: 1379204Hom.: 1 Cov.: 32 AF XY: 0.00000735 AC XY: 5AN XY: 680020
GnomAD4 exome
AF:
AC:
13
AN:
1379204
Hom.:
Cov.:
32
AF XY:
AC XY:
5
AN XY:
680020
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152156Hom.: 0 Cov.: 34 AF XY: 0.0000269 AC XY: 2AN XY: 74324
GnomAD4 genome
AF:
AC:
2
AN:
152156
Hom.:
Cov.:
34
AF XY:
AC XY:
2
AN XY:
74324
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 07, 2023 | - - |
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 04, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at